ConductScience.org, home

Paper344347

Effect of thymidine on activity of trimethoprim and sulphamethoxazole.

Stokes A and 1 other. J Clin Pathol, 1978. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Effect of thymidine on activity of trimethoprim and sulphamethoxazole. Papers, record 344347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/344347

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of thymidine on activity of trimethoprim and sulphamethoxazole.
PubMed
Journal
J Clin Pathol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stokes AA
2Lacey RWR W

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SulfamethoxazoleMajor topic
ThymidineMajor topic
TrimethoprimMajor topic
Bacteriuria
Escherichia coli
Humans
Staphylococcus aureus

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114329476IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.J Bacteriol1965https://conductscience.org/library/papers/14329476PubMed
2871632Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.Br Med J1977https://conductscience.org/library/papers/871632PubMed
356651Thymine-requiring bacteria associated with co-trimoxazole therapy.Lancet1976https://conductscience.org/library/papers/56651PubMed
44584067Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo.J Gen Microbiol1973https://conductscience.org/library/papers/4584067PubMed
54590994Letter: Co-trimoxazole resistance.Br Med J1974https://conductscience.org/library/papers/4590994PubMed
64570620Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.J Clin Pathol1972https://conductscience.org/library/papers/4570620PubMed
74463825Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.Antibiot Chemother (1971)1974https://conductscience.org/library/papers/4463825PubMed
84425219Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.J Clin Pathol1974https://conductscience.org/library/papers/4425219PubMed
94752317Letter: Is co-trimoxazole bactericidal in sputum?Br Med J1973https://conductscience.org/library/papers/4752317PubMed
10777036Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.J Clin Pathol1976https://conductscience.org/library/papers/777036PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
39950956Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines.ACS Infect Dis2025https://conductscience.org/library/papers/39950956PubMed
39445807Mechanisms of Staphylococcus aureus survival of trimethoprim-sulfamethoxazole-induced thymineless death.mBio2024https://conductscience.org/library/papers/39445807PubMed
39036800The effect of antibiotic selection on collateral effects and evolvability of uropathogenic Escherichia coli.NPJ Antimicrob Resist2024https://conductscience.org/library/papers/39036800PubMed
35889189Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.Microorganisms2022https://conductscience.org/library/papers/35889189PubMed
34704796Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus.Microbiol Spectr2021https://conductscience.org/library/papers/34704796PubMed
33526491In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/33526491PubMed
31591126Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31591126PubMed
29073080Maladaptive DNA repair is the ultimate contributor to the death of trimethoprim-treated cells under aerobic and anaerobic conditions.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/29073080PubMed
23052313Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?J Clin Microbiol2012https://conductscience.org/library/papers/23052313PubMed
20028816Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20028816PubMed
19405550Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management.Drugs2009https://conductscience.org/library/papers/19405550PubMed
16811110Thymidine mutants.J Clin Pathol1978https://conductscience.org/library/papers/16811110PubMed
9145866Efficacy of trimethoprim in murine experimental infection with a thymidine kinase-deficient mutant of Escherichia coli.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9145866PubMed
7427374Bacterial resistance to trimethoprim.Br Med J1980https://conductscience.org/library/papers/7427374PubMed
7261250Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7261250PubMed
7049657Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.Drugs1982https://conductscience.org/library/papers/7049657PubMed
6759092Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs1982https://conductscience.org/library/papers/6759092PubMed
3497170Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.J Clin Microbiol1987https://conductscience.org/library/papers/3497170PubMed
3494425Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3494425PubMed
533255Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/533255PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/344347

GET https://conductscience.org/api/papers/v1/344347/cited_by?page=2